Breaking News Instant updates and real-time market news.

AXS

Axis Capital

$58.84

-0.1 (-0.17%)

17:23
11/19/19
11/19
17:23
11/19/19
17:23

Axis Capital files automatic mixed securities shelf

  • 20

    Nov

AXS Axis Capital
$58.84

-0.1 (-0.17%)

05/23/19
UBSW
05/23/19
UPGRADE
UBSW
Buy
Axis Capital upgraded to Buy from Neutral at UBS
07/19/19
BUCK
07/19/19
UPGRADE
Target $70
BUCK
Buy
Axis Capital upgraded to Buy from Neutral at Buckingham
Buckingham analyst Amit Kumar upgraded Axis Capital to Buy from Neutral and raised his price target for the shares to $70 from $60.
07/19/19
BUCK
07/19/19
NO CHANGE
BUCK
Buckingham upgrades Axis Capital, downgrades Arch, Travelers ahead of earnings
As previously reported, Buckingham analyst Amit Kumar upgraded Axis Capital (AXS) to Buy from Neutral and downgraded Arch Capital (ACGL) and Travelers (TRV), both to Neutral from Buy, ahead of Q2 earnings for the insurance/reinsurance space. He believes that Axis' relative discount is no longer justified given positive pricing commentary in reinsurance and E&S markets and his analysis of reserves and he thinks the stock is best positioned to catch up to its peer group, Kumar said in his sector preview note. He raised his price target on Axis shares to $70 from $60. Arch currently trades above its 5 year average multiple to next twelve months consensus book value and he feels the stock is fully priced, said Kumar, who keeps a $38 price target on the stock. In terms of Travelers, Kumar also cites valuation and recommends that investors rotate into Hartford Financial (HIG) given its valuation discount and the fact that it should also benefit from rate increases.
09/09/19
MKMP
09/09/19
NO CHANGE
Target $75
MKMP
Buy
Axis Capital price target raised to $75 from $70 at MKM Partners
MKM Partners analyst Harry Fong raised his price target on Axis Capital to $75 and kept his Buy rating after meeting with its CFO to discuss the company's progress in integrating its Novae acquisition and its reunderwriting initiatives. The analyst also notes that after reporting a "very good" Q2, it appears that Axis Capital may have reached a point where its earnings will start to reflect his bullish expectations. Fong adds that while the company still has "more to accomplish", such as reducing its catastrophe exposure to earnings volatility, the results of Q2 suggest that there is a "major change" in the direction of the company.

TODAY'S FREE FLY STORIES

08:52
12/09/19
12/09
08:52
12/09/19
08:52
Conference/Events
Jefferies European economist to hold an analyst/industry conference call »

European Economist Owen,…

LEA

Lear

$124.81

4.05 (3.35%)

08:51
12/09/19
12/09
08:51
12/09/19
08:51
Conference/Events
Lear management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

WWD

Woodward

$122.27

2.55 (2.13%)

08:49
12/09/19
12/09
08:49
12/09/19
08:49
Recommendations
Woodward analyst commentary  »

Woodward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JKS

JinkoSolar

$20.32

0.56 (2.83%)

08:49
12/09/19
12/09
08:49
12/09/19
08:49
Conference/Events
JinkoSolar management to meet with Roth Capital »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ABEO

Abeona Therapeutics

$3.00

0.25 (9.09%)

08:46
12/09/19
12/09
08:46
12/09/19
08:46
Hot Stocks
Abeona Therapeutics cleared to initiate EB-101 Phase 3 clinical trial »

Abeona Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$85.02

-0.56 (-0.65%)

08:46
12/09/19
12/09
08:46
12/09/19
08:46
Conference/Events
Jacobs Engineering management to meet with Seaport Global »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

DK

Delek US

$34.30

0.99 (2.97%)

, MPC

Marathon Petroleum

$60.17

0.4 (0.67%)

08:46
12/09/19
12/09
08:46
12/09/19
08:46
Downgrade
Delek US, Marathon Petroleum rating change  »

JPMorgan downgrades Delek…

DK

Delek US

$34.30

0.99 (2.97%)

MPC

Marathon Petroleum

$60.17

0.4 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BZUN

Baozun

$35.29

-0.06 (-0.17%)

, AIMT

Aimmune

$29.67

0.51 (1.75%)

08:45
12/09/19
12/09
08:45
12/09/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

BZUN

Baozun

$35.29

-0.06 (-0.17%)

AIMT

Aimmune

$29.67

0.51 (1.75%)

MED

Medifast

$90.67

0.48 (0.53%)

CGC

Canopy Growth

$18.65

0.07 (0.38%)

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$15.11

-0.8 (-5.03%)

SCO

Scor ADR

$13.14

-0.3 (-2.23%)

BRFS

BRF S.A.

$8.87

0.22 (2.54%)

ET

Energy Transfer LP

$11.50

-0.1 (-0.86%)

RVLV

Revolve Group

$16.74

-0.46 (-2.67%)

DO

Diamond Offshore

$6.01

0.44 (7.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

INFN

Infinera

$6.12

0.115 (1.92%)

08:44
12/09/19
12/09
08:44
12/09/19
08:44
Conference/Events
Infinera management to meet with B. Riley FBR »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

DPLO

Diplomat Pharmacy

$5.82

0.22 (3.93%)

08:43
12/09/19
12/09
08:43
12/09/19
08:43
Downgrade
Diplomat Pharmacy rating change  »

Diplomat Pharmacy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IHRT

iHeartMedia

$14.59

-0.24 (-1.62%)

08:42
12/09/19
12/09
08:42
12/09/19
08:42
Conference/Events
iHeartMedia management to meet with Wolfe Research »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

IDA

Idacorp

$104.61

-0.03 (-0.03%)

08:40
12/09/19
12/09
08:40
12/09/19
08:40
Conference/Events
Idacorp management to meet with Mizuho »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

ATVI

Activision Blizzard

$55.21

0.22 (0.40%)

08:39
12/09/19
12/09
08:39
12/09/19
08:39
Recommendations
Activision Blizzard analyst commentary  »

Activision Blizzard price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SNY

Sanofi

$46.05

-0.04 (-0.09%)

08:38
12/09/19
12/09
08:38
12/09/19
08:38
Hot Stocks
Sanofi vaccines unit enters agreement with HHS to increase production capability »

Sanofi Pasteur, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

RFIL

RF Industries

$5.82

0.07 (1.22%)

08:38
12/09/19
12/09
08:38
12/09/19
08:38
Hot Stocks
RF Industries appoints Ray Bibisi as Chief Revenue Officer »

RF Industries announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JJSF

J & J Snack Foods

$188.98

0.94 (0.50%)

08:37
12/09/19
12/09
08:37
12/09/19
08:37
Downgrade
J & J Snack Foods rating change  »

J & J Snack Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$15.91

-0.02 (-0.13%)

08:37
12/09/19
12/09
08:37
12/09/19
08:37
Conference/Events
HP Enterprise management to meet with Loop Capital »

Dinner Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

ATR

AptarGroup

$112.05

-0.015 (-0.01%)

08:36
12/09/19
12/09
08:36
12/09/19
08:36
Hot Stocks
AptarGroup Unidose Liquid System approved by FDA »

AptarGroup announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTON

Peloton

$32.56

1.24 (3.96%)

08:35
12/09/19
12/09
08:35
12/09/19
08:35
Recommendations
Peloton analyst commentary  »

Peloton remains positoned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

FLWS

1-800-Flowers.com

$12.83

-0.09 (-0.70%)

08:34
12/09/19
12/09
08:34
12/09/19
08:34
Conference/Events
1-800-Flowers.com management to meet with DA Davidson »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

PDLI

PDL BioPharma

$2.96

-0.035 (-1.17%)

, EVFM

Evofem

$6.88

0.455 (7.09%)

08:33
12/09/19
12/09
08:33
12/09/19
08:33
Hot Stocks
PDL BioPharma completes strategic review, to initiate new process »

PDL BioPharma (PDLI)…

PDLI

PDL BioPharma

$2.96

-0.035 (-1.17%)

EVFM

Evofem

$6.88

0.455 (7.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EA

Electronic Arts

$103.30

1.22 (1.20%)

08:32
12/09/19
12/09
08:32
12/09/19
08:32
Recommendations
Electronic Arts analyst commentary  »

Electronic Arts price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

ARQL

ArQule

$9.67

0.15 (1.58%)

, AUTL

Autolus Therapeutics

$14.60

-0.18 (-1.22%)

08:30
12/09/19
12/09
08:30
12/09/19
08:30
Conference/Events
Roth Capital to hold events »

Roth Capital KOL Events…

ARQL

ArQule

$9.67

0.15 (1.58%)

AUTL

Autolus Therapeutics

$14.60

-0.18 (-1.22%)

BGNE

BeiGene

$186.89

-2.3 (-1.22%)

BLUE

Bluebird Bio

$79.51

-1.24 (-1.54%)

BMY

Bristol-Myers

$59.94

0.435 (0.73%)

CC

Chemours

$16.68

1.62 (10.76%)

CRSP

Crispr Therapeutics

$72.19

1.47 (2.08%)

FTSV

Forty Seven

$14.40

0.23 (1.62%)

JNJ

Johnson & Johnson

$140.36

0.79 (0.57%)

LLY

Eli Lilly

$119.59

-0.175 (-0.15%)

LOXO

Loxo Oncology

$0.00

(0.00%)

SGMO

Sangamo

$11.65

0.05 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 11

    Dec

  • 17

    Dec

  • 21

    Jan

  • 30

    Jan

  • 27

    Feb

TFC

Taiwan Greater China Fund

$54.16

0.66 (1.23%)

, BBT

BB&T

$54.16

0.66 (1.23%)

08:30
12/09/19
12/09
08:30
12/09/19
08:30
Options
One new option listing and two option delistings on December 9th »

New option listings for…

TFC

Taiwan Greater China Fund

$54.16

0.66 (1.23%)

BBT

BB&T

$54.16

0.66 (1.23%)

STI

SunTrust

$70.09

0.83 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

CWBHF

Charlotte's Web

$0.00

(0.00%)

08:29
12/09/19
12/09
08:29
12/09/19
08:29
Initiation
Charlotte's Web initiated  »

Compass Point starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.